Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 4/2008

01-04-2008 | Glaucoma

Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens

Authors: Stephanie C. Joachim, Jan Reichelt, Simone Berneiser, Norbert Pfeiffer, Franz H. Grus

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 4/2008

Login to get access

Abstract

Background

The aim of this study was to gain more information about the possible immunological mechanisms in glaucoma. We analyzed the complex autoantibody patterns against human optic nerve antigens in sera of patients with glaucoma and tried to identify important antigens.

Methods

Sera of 133 patients were included: healthy control subjects (n = 44), primary open-angle glaucoma (n = 44), and normal tension glaucoma patients (n = 45). The sera were tested against Western blots of human optic nerve, and antibody bands were visualized with chloronaphthol. IgG antibody patterns were analyzed by multivariate statistical techniques, and the most significant antigens were identified by mass spectrometry (Maldi-TOFTOF).

Results

All subjects, even healthy ones, showed different and complex antibody patterns. Glaucoma groups showed specific up- and down-regulations of antibody reactivities compared to the control group. The multivariate analysis of discriminance found significant differences (P < 0.05) in IgG antibody profiles against human optic nerve antigens between both glaucoma groups and healthy subjects. The identified antigens include: myelin basic protein (up-regulated in the POAG group), glial fibrillary acidic protein (down-regulated in the glaucoma groups), and vimentin (down-regulated in the glaucoma groups in comparison to controls).

Conclusions

Using human optic nerve antigen, we were able to demonstrate that complex IgG autoantibody patterns exist in sera of patients with glaucoma. Large correlations between the given and our previous studies using bovine optic nerve antigens could be seen. Furthermore, anti-myelin basic protein antibodies, which can also be detected in patients with multiple sclerosis, were found in sera of glaucoma patients.
Literature
1.
2.
go back to reference Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267PubMedCrossRef Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267PubMedCrossRef
3.
go back to reference Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC (1995) Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61(1):33–44PubMedCrossRef Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC (1995) Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 61(1):33–44PubMedCrossRef
4.
go back to reference Flammer J, Orgul S, Costa VP et al (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21(4):359–393PubMedCrossRef Flammer J, Orgul S, Costa VP et al (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21(4):359–393PubMedCrossRef
5.
go back to reference Osborne NN, Melena J, Chidlow G, Wood JP (2001) A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol 85(10):1252–1259PubMedCrossRef Osborne NN, Melena J, Chidlow G, Wood JP (2001) A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol 85(10):1252–1259PubMedCrossRef
6.
go back to reference Kitazawa Y (2001) Open-angle glaucoma clinical presentation and management. Nippon Ganka Gakkai Zasshi 105(12):828–842PubMed Kitazawa Y (2001) Open-angle glaucoma clinical presentation and management. Nippon Ganka Gakkai Zasshi 105(12):828–842PubMed
7.
go back to reference Tezel G, Hernandez R, Wax MB (2000) Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch Ophthalmol 118(4):511–518PubMed Tezel G, Hernandez R, Wax MB (2000) Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch Ophthalmol 118(4):511–518PubMed
8.
go back to reference Tezel G, Seigel GM, Wax MB (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 39(12):2277–2287PubMed Tezel G, Seigel GM, Wax MB (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 39(12):2277–2287PubMed
9.
go back to reference Wax MB, Tezel G, Kawase K, Kitazawa Y (2001) Serum autoantibodies to heat shock proteins in glaucoma patients from Japan and the United States. Ophthalmology 108(2):296–302PubMedCrossRef Wax MB, Tezel G, Kawase K, Kitazawa Y (2001) Serum autoantibodies to heat shock proteins in glaucoma patients from Japan and the United States. Ophthalmology 108(2):296–302PubMedCrossRef
10.
go back to reference Maruyama I, Ikeda Y, Nakazawa M, Ohguro H (2002) Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients. Tohoku J Exp Med 197(3):125–132PubMedCrossRef Maruyama I, Ikeda Y, Nakazawa M, Ohguro H (2002) Clinical roles of serum autoantibody against neuron-specific enolase in glaucoma patients. Tohoku J Exp Med 197(3):125–132PubMedCrossRef
11.
go back to reference Grus FH, Joachim SC, Bruns K et al (2006) Serum autoantibodies to {alpha}-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 47(3):968–976PubMedCrossRef Grus FH, Joachim SC, Bruns K et al (2006) Serum autoantibodies to {alpha}-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 47(3):968–976PubMedCrossRef
12.
go back to reference Yang J, Tezel G, Patil RV et al (2001) Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci 42(6):1273–1276PubMed Yang J, Tezel G, Patil RV et al (2001) Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci 42(6):1273–1276PubMed
13.
go back to reference Tezel G, Edward DP, Wax MB (1999) Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 117(7):917–924PubMed Tezel G, Edward DP, Wax MB (1999) Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 117(7):917–924PubMed
15.
go back to reference Reichelt J, Joachim SC, Pfeiffer N, Grus FH (2007) Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. accepted in Curr Eye Res Reichelt J, Joachim SC, Pfeiffer N, Grus FH (2007) Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. accepted in Curr Eye Res
16.
go back to reference Grus FH, Augustin AJ, Zimmermann CW (1997) Computer-supported analysis (MegaBlot) of allopurinol-induced changes in the autoantibody repertoires of rats suffering from experimental lens-induced uveitis. Electrophoresis 18(3–4):516–519PubMedCrossRef Grus FH, Augustin AJ, Zimmermann CW (1997) Computer-supported analysis (MegaBlot) of allopurinol-induced changes in the autoantibody repertoires of rats suffering from experimental lens-induced uveitis. Electrophoresis 18(3–4):516–519PubMedCrossRef
17.
go back to reference Singer HS, Loiselle CR, Lee O et al (2003) Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 136(1–2):154–161PubMedCrossRef Singer HS, Loiselle CR, Lee O et al (2003) Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol 136(1–2):154–161PubMedCrossRef
18.
go back to reference Wendlandt JT, Grus FH, Hansen BH, Singer HS (2001) Striatal antibodies in children with Tourette’s syndrome: multivariate discriminant analysis of IgG repertoires. J Neuroimmunol 119(1):106–113PubMedCrossRef Wendlandt JT, Grus FH, Hansen BH, Singer HS (2001) Striatal antibodies in children with Tourette’s syndrome: multivariate discriminant analysis of IgG repertoires. J Neuroimmunol 119(1):106–113PubMedCrossRef
19.
go back to reference Zimmermann CW, Grus FH, Dux R (1995) Multivariate statistical comparison of autoantibody-repertoires (western blots) by discriminant analysis. Electrophoresis 16(6):941–947PubMedCrossRef Zimmermann CW, Grus FH, Dux R (1995) Multivariate statistical comparison of autoantibody-repertoires (western blots) by discriminant analysis. Electrophoresis 16(6):941–947PubMedCrossRef
20.
go back to reference Joachim SC, Pfeiffer N, Grus FH (2005) Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol 243(8):817–823PubMedCrossRef Joachim SC, Pfeiffer N, Grus FH (2005) Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol 243(8):817–823PubMedCrossRef
21.
go back to reference Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N (2004) Complex autoantibody repertoires in patients with glaucoma. Mol Vis 10:132–137PubMed Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N (2004) Complex autoantibody repertoires in patients with glaucoma. Mol Vis 10:132–137PubMed
22.
go back to reference Romano C, Barrett DA, Li Z et al (1995) Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma. Invest Ophthalmol Vis Sci 36(10):1968–1975PubMed Romano C, Barrett DA, Li Z et al (1995) Anti-rhodopsin antibodies in sera from patients with normal-pressure glaucoma. Invest Ophthalmol Vis Sci 36(10):1968–1975PubMed
23.
go back to reference Wax MB, Tezel G, Saito I et al (1998) Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 125(2):145–157PubMedCrossRef Wax MB, Tezel G, Saito I et al (1998) Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 125(2):145–157PubMedCrossRef
24.
go back to reference Joachim SC, Grus FH, Pfeiffer N (2003) Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur J Ophthalmol 13(9–10):752–758PubMed Joachim SC, Grus FH, Pfeiffer N (2003) Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur J Ophthalmol 13(9–10):752–758PubMed
25.
go back to reference Vojdani A, Vojdani E, Cooper E (2003) Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. J Intern Med 254(4):363–374PubMedCrossRef Vojdani A, Vojdani E, Cooper E (2003) Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis. J Intern Med 254(4):363–374PubMedCrossRef
26.
go back to reference Chamczuk AJ, Ursell M, O’Connor P et al (2002) A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. J Immunol Methods 262(1–2):21–27PubMedCrossRef Chamczuk AJ, Ursell M, O’Connor P et al (2002) A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. J Immunol Methods 262(1–2):21–27PubMedCrossRef
27.
go back to reference Reindl M, Linington C, Brehm U et al (1999) Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122 (Pt 11):2047–2056PubMedCrossRef Reindl M, Linington C, Brehm U et al (1999) Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain 122 (Pt 11):2047–2056PubMedCrossRef
28.
go back to reference Schmidt S, Haase CG, Bezman L et al (2001) Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol 119(1):88–94PubMedCrossRef Schmidt S, Haase CG, Bezman L et al (2001) Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunol 119(1):88–94PubMedCrossRef
29.
go back to reference Paterson PY, Day ED, Whitacre CC et al (1981) Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis. J Neurol Sci 52(1):37–51PubMedCrossRef Paterson PY, Day ED, Whitacre CC et al (1981) Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis. J Neurol Sci 52(1):37–51PubMedCrossRef
30.
go back to reference Warren KG, Catz I (1994) Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J Neurol Sci 121(1):66–73PubMedCrossRef Warren KG, Catz I (1994) Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J Neurol Sci 121(1):66–73PubMedCrossRef
31.
go back to reference Guo L, Li Y, Lin H et al (2004) Evaluation of a rat model of experimental autoimmune encephalomyelitis with human MBP as antigen. Cell Mol Immunol 1(5):387–391PubMed Guo L, Li Y, Lin H et al (2004) Evaluation of a rat model of experimental autoimmune encephalomyelitis with human MBP as antigen. Cell Mol Immunol 1(5):387–391PubMed
32.
go back to reference Schluesener HJ, Sobel RA, Linington C, Weiner HL (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139(12):4016–4021PubMed Schluesener HJ, Sobel RA, Linington C, Weiner HL (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139(12):4016–4021PubMed
33.
go back to reference Berger T, Rubner P, Schautzer F et al (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349(2):139–145PubMedCrossRef Berger T, Rubner P, Schautzer F et al (2003) Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 349(2):139–145PubMedCrossRef
34.
go back to reference Tomassini V, De Giglio L, Reindl M et al (2007) Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler 13(9):1086-1094PubMedCrossRef Tomassini V, De Giglio L, Reindl M et al (2007) Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler 13(9):1086-1094PubMedCrossRef
35.
go back to reference O’Riordan JI, Thompson AJ, Kingsley DP et al (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 121 (Pt 3):495–503PubMedCrossRef O’Riordan JI, Thompson AJ, Kingsley DP et al (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 121 (Pt 3):495–503PubMedCrossRef
36.
go back to reference Lim ET, Berger T, Reindl M et al (2005) Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Mult Scler 11(4):492–494PubMedCrossRef Lim ET, Berger T, Reindl M et al (2005) Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. Mult Scler 11(4):492–494PubMedCrossRef
37.
go back to reference Norgren N, Sundstrom P, Svenningsson A et al (2004) Neurofilament and glial fibrillary acidic protein in multiple sclerosis. Neurology 63(9):1586–1590PubMed Norgren N, Sundstrom P, Svenningsson A et al (2004) Neurofilament and glial fibrillary acidic protein in multiple sclerosis. Neurology 63(9):1586–1590PubMed
38.
go back to reference Sanna G, Piga M, Terryberry JW et al (2000) Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 9(8):573–583PubMedCrossRef Sanna G, Piga M, Terryberry JW et al (2000) Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 9(8):573–583PubMedCrossRef
39.
go back to reference Chen H, Weber AJ (2002) Expression of glial fibrillary acidic protein and glutamine synthetase by Muller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor. Glia 38(2):115–125PubMedCrossRef Chen H, Weber AJ (2002) Expression of glial fibrillary acidic protein and glutamine synthetase by Muller cells after optic nerve damage and intravitreal application of brain-derived neurotrophic factor. Glia 38(2):115–125PubMedCrossRef
40.
go back to reference Lam TT, Kwong JM, Tso MO (2003) Early glial responses after acute elevated intraocular pressure in rats. Invest Ophthalmol Vis Sci 44(2):638–645PubMedCrossRef Lam TT, Kwong JM, Tso MO (2003) Early glial responses after acute elevated intraocular pressure in rats. Invest Ophthalmol Vis Sci 44(2):638–645PubMedCrossRef
41.
go back to reference Singh VK, Warren R, Averett R, Ghaziuddin M (1997) Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17(1):88–90PubMedCrossRef Singh VK, Warren R, Averett R, Ghaziuddin M (1997) Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17(1):88–90PubMedCrossRef
42.
go back to reference Stuart BM, Gregson NA (1998) Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein. Br J Rheumatol 37(12):1355–1357PubMedCrossRef Stuart BM, Gregson NA (1998) Cerebral calcification in a patient with systemic lupus erythematosus and a monoclonal IgG reactive with glial fibrillary acidic protein. Br J Rheumatol 37(12):1355–1357PubMedCrossRef
43.
go back to reference Shibuya M, Matsuki N, Fujiwara K et al (2007) Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis. J Vet Med Sci 69(3):241–245PubMedCrossRef Shibuya M, Matsuki N, Fujiwara K et al (2007) Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis. J Vet Med Sci 69(3):241–245PubMedCrossRef
44.
go back to reference Lewis GP, Erickson PA, Guerin CJ et al (1989) Changes in the expression of specific Muller cell proteins during long-term retinal detachment. Exp Eye Res 49(1):93–111PubMedCrossRef Lewis GP, Erickson PA, Guerin CJ et al (1989) Changes in the expression of specific Muller cell proteins during long-term retinal detachment. Exp Eye Res 49(1):93–111PubMedCrossRef
45.
go back to reference Brown C, Pedersen J, Underwood JR et al (1986) Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin. J Clin Lab Immunol 19(1):1–4PubMed Brown C, Pedersen J, Underwood JR et al (1986) Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin. J Clin Lab Immunol 19(1):1–4PubMed
46.
go back to reference Yang Y, Fujita J, Bandoh S et al (2002) Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. Clin Exp Immunol 128(1):169–174PubMedCrossRef Yang Y, Fujita J, Bandoh S et al (2002) Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. Clin Exp Immunol 128(1):169–174PubMedCrossRef
47.
go back to reference Poletaev A, Osipenko L (2003) General network of natural autoantibodies as immunological homunculus (Immunculus). Autoimmun Rev 2(5):264–271PubMedCrossRef Poletaev A, Osipenko L (2003) General network of natural autoantibodies as immunological homunculus (Immunculus). Autoimmun Rev 2(5):264–271PubMedCrossRef
48.
go back to reference Kulberg AY (1999) Immunoglobulins and Antibodies. Russ J Immunol 4(3):241–242PubMed Kulberg AY (1999) Immunoglobulins and Antibodies. Russ J Immunol 4(3):241–242PubMed
49.
go back to reference Erlanger BF (1989) Some thoughts on the structural basis of internal imagery. Immunol Today 10(5):151–152PubMedCrossRef Erlanger BF (1989) Some thoughts on the structural basis of internal imagery. Immunol Today 10(5):151–152PubMedCrossRef
50.
51.
go back to reference Shmerling RH (2003) Autoantibodies in systemic lupus erythematosus-there before you know it. N Engl J Med 349(16):1499–1500PubMedCrossRef Shmerling RH (2003) Autoantibodies in systemic lupus erythematosus-there before you know it. N Engl J Med 349(16):1499–1500PubMedCrossRef
52.
go back to reference Arbuckle MR, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526–1533PubMedCrossRef Arbuckle MR, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526–1533PubMedCrossRef
Metadata
Title
Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens
Authors
Stephanie C. Joachim
Jan Reichelt
Simone Berneiser
Norbert Pfeiffer
Franz H. Grus
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 4/2008
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-007-0737-8

Other articles of this Issue 4/2008

Graefe's Archive for Clinical and Experimental Ophthalmology 4/2008 Go to the issue